Pro Medicus Limited Stock News

Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

Pro Medicus Limited (OTCPK:PMCUF) Q4 2023 Earnings Conference Call August 14, 2023 9:00 PM ET Company Participants Sam Hupert - CEO Clayton Hatch - CFO Conference Call Participants Gary Sherriff - RBC

Pro Medicus Limited (OTCPK:PMCUF) Q2 2023 Earnings Conference Call February 14, 2023 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Confer

Pro Medicus Limited (OTCPK:PMCUF) Q4 2022 Earnings Conference Call August 17, 2022 9:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fina

ro Medicus Limited (OTCPK:PMCUF) Q2 2022 Earnings Conference Call February 15, 2022 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fin

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript

Pro Medicus Limited (OTCMKTS:PMCUF) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 7,300 shares, a decrease of 22.3% from the October 31st total of 9,400 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is []

The dip in Pro Medicus shares is accompanied by a sector-wide sell-off. The post The Pro Medicus (ASX:PME) share price has dropped 8% in 3 days. Whats going on? appeared first on The Motley Fool Australia .

Pro Medicus Limited (OTCMKTS:PMCUF) was the recipient of a large decline in short interest in November. As of November 15th, there was short interest totalling 7,300 shares, a decline of 22.3% from the October 31st total of 9,400 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is currently 14.6 days. []

The ASX continued its rollercoaster ride, clawing back losses once again in a volatile session, with banks and resources stocks proving the positive backbone.

The ASX continued its rollercoaster ride, clawing back losses once again in a volatile session, with banks and resources stocks proving the positive backbone.

SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing the latest version of the Visage ® 7 Enterprise Imaging Platform, purpose built

Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript